This announcement is a separate document:
天茂集团：天茂集团第九届董事会提名委员会关于董事候选人任职资格的审查意见
Hubei Biocause Pharmaceutical: The board of directors nomination committee of Hubei Biocause Pharmaceutical's 9th session has reviewed the qualifications of director candidates.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.